ArticleJournal of cancer research and clinical oncology2023

PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target.

Naoya Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.